Klf6 Protects β-cells Against Insulin Resistance-induced Dedifferentiation

Overview

Journal Mol Metab

Specialty Cell Biology

Date 2020 Apr 4

PMID 32244185

Citations 10

Authors

Christopher Dumayne

David Tarussio

Ana Rodriguez Sanchez-Archidona

Alexandre Picard

Davide Basco

Xavier Pascal Berney

Mark Ibberson

Bernard Thorens

Affiliations

Soon will be listed here.

Abstract

Objectives: In the pathogenesis of type 2 diabetes, development of insulin resistance triggers an increase in pancreatic β-cell insulin secretion capacity and β-cell number. Failure of this compensatory mechanism is caused by a dedifferentiation of β-cells, which leads to insufficient insulin secretion and diabetic hyperglycemia. The β-cell factors that normally protect against dedifferentiation remain poorly defined. Here, through a systems biology approach, we identify the transcription factor Klf6 as a regulator of β-cell adaptation to metabolic stress.

Methods: We used a β-cell specific Klf6 knockout mouse model to investigate whether Klf6 may be a potential regulator of β-cell adaptation to a metabolic stress.

Results: We show that inactivation of Klf6 in β-cells blunts their proliferation induced by the insulin resistance of pregnancy, high-fat high-sucrose feeding, and insulin receptor antagonism. Transcriptomic analysis showed that Klf6 controls the expression of β-cell proliferation genes and, in the presence of insulin resistance, it prevents the down-expression of genes controlling mature β-cell identity and the induction of disallowed genes that impair insulin secretion. Its expression also limits the transdifferentiation of β-cells into α-cells.

Conclusion: Our study identifies a new transcription factor that protects β-cells against dedifferentiation, and which may be targeted to prevent diabetes development.

Citing Articles

A mechanism-informed deep neural network enables prioritization of regulators that drive cell state transitions.

Xi X, Li J, Jia J, Meng Q, Li C, Wang X Nat Commun. 2025; 16(1):1284.

PMID: 39900922 PMC: 11790924. DOI: 10.1038/s41467-025-56475-9.

A multiorgan map of metabolic, signaling, and inflammatory pathways that coordinately control fasting glycemia in mice.

Mehl F, Sanchez-Archidona A, Meitil I, Gerl M, Cruciani-Guglielmacci C, Wigger L iScience. 2024; 27(11):111134.

PMID: 39507247 PMC: 11539597. DOI: 10.1016/j.isci.2024.111134.

Studies on Treatment Within the Scope of Medical Biotechnology for Pancreatic Diseases.

Aylar D, Karatug Kacar A Mol Biotechnol. 2024; .

PMID: 38627328 DOI: 10.1007/s12033-024-01142-5.

The Role of Krüppel-like Factors in Pancreatic Physiology and Pathophysiology.

Giarrizzo M, LaComb J, Bialkowska A Int J Mol Sci. 2023; 24(10).

PMID: 37239940 PMC: 10218095. DOI: 10.3390/ijms24108589.

Febuxostat Alleviates Allergic Rhinitis by Inhibiting Inflammation and Monocyte Adhesion in Human Nasal Epithelial Cells via Regulating KLF6.

Yao Y, Wei R, Jiang H Evid Based Complement Alternat Med. 2022; 2022:9092311.

PMID: 36118091 PMC: 9477640. DOI: 10.1155/2022/9092311.

References

Rutter G, Pullen T, Hodson D, Martinez-Sanchez A . Pancreatic β-cell identity, glucose sensing and the control of insulin secretion. Biochem J. 2015; 466(2):203-18. DOI: 10.1042/BJ20141384. View

Rieck S, Kaestner K . Expansion of beta-cell mass in response to pregnancy. Trends Endocrinol Metab. 2009; 21(3):151-8. PMC: 3627215. DOI: 10.1016/j.tem.2009.11.001. View

Schaffer L, Brand C, Hansen B, Ribel U, Shaw A, Slaaby R . A novel high-affinity peptide antagonist to the insulin receptor. Biochem Biophys Res Commun. 2008; 376(2):380-3. DOI: 10.1016/j.bbrc.2008.08.151. View

Bartrons R, Simon-Molas H, Rodriguez-Garcia A, Castano E, Navarro-Sabate A, Manzano A . Fructose 2,6-Bisphosphate in Cancer Cell Metabolism. Front Oncol. 2018; 8:331. PMC: 6131595. DOI: 10.3389/fonc.2018.00331. View

Cigliola V, Ghila L, Thorel F, van Gurp L, Baronnier D, Oropeza D . Pancreatic islet-autonomous insulin and smoothened-mediated signalling modulate identity changes of glucagon α-cells. Nat Cell Biol. 2018; 20(11):1267-1277. PMC: 6215453. DOI: 10.1038/s41556-018-0216-y. View

Laitman B, Asp L, Mariani J, Zhang J, Liu J, Sawai S . The Transcriptional Activator Krüppel-like Factor-6 Is Required for CNS Myelination. PLoS Biol. 2016; 14(5):e1002467. PMC: 4877075. DOI: 10.1371/journal.pbio.1002467. View

Sakano D, Shiraki N, Kikawa K, Yamazoe T, Kataoka M, Umeda K . VMAT2 identified as a regulator of late-stage β-cell differentiation. Nat Chem Biol. 2013; 10(2):141-8. DOI: 10.1038/nchembio.1410. View

Anders S, Pyl P, Huber W . HTSeq--a Python framework to work with high-throughput sequencing data. Bioinformatics. 2014; 31(2):166-9. PMC: 4287950. DOI: 10.1093/bioinformatics/btu638. View

McConnell B, Yang V . Mammalian Krüppel-like factors in health and diseases. Physiol Rev. 2010; 90(4):1337-81. PMC: 2975554. DOI: 10.1152/physrev.00058.2009. View

10.

Ni Q, Gu Y, Xie Y, Yin Q, Zhang H, Nie A . Raptor regulates functional maturation of murine beta cells. Nat Commun. 2017; 8:15755. PMC: 5472774. DOI: 10.1038/ncomms15755. View

11.

Dahan T, Ziv O, Horwitz E, Zemmour H, Lavi J, Swisa A . Pancreatic β-Cells Express the Fetal Islet Hormone Gastrin in Rodent and Human Diabetes. Diabetes. 2016; 66(2):426-436. PMC: 5248995. DOI: 10.2337/db16-0641. View

12.

Qi W, Holian J, Tan C, Kelly D, Chen X, Pollock C . The roles of Kruppel-like factor 6 and peroxisome proliferator-activated receptor-γ in the regulation of macrophage inflammatory protein-3α at early onset of diabetes. Int J Biochem Cell Biol. 2010; 43(3):383-92. DOI: 10.1016/j.biocel.2010.11.008. View

13.

Cornu M, Modi H, Kawamori D, Kulkarni R, Joffraud M, Thorens B . Glucagon-like peptide-1 increases beta-cell glucose competence and proliferation by translational induction of insulin-like growth factor-1 receptor expression. J Biol Chem. 2010; 285(14):10538-45. PMC: 2856261. DOI: 10.1074/jbc.M109.091116. View

14.

Bechmann L, Vetter D, Ishida J, Hannivoort R, Lang U, Kocabayoglu P . Post-transcriptional activation of PPAR alpha by KLF6 in hepatic steatosis. J Hepatol. 2013; 58(5):1000-6. PMC: 3631429. DOI: 10.1016/j.jhep.2013.01.020. View

15.

Sirach E, Bureau C, Peron J, Pradayrol L, Vinel J, Buscail L . KLF6 transcription factor protects hepatocellular carcinoma-derived cells from apoptosis. Cell Death Differ. 2007; 14(6):1202-10. DOI: 10.1038/sj.cdd.4402114. View

16.

Kim-Muller J, Fan J, Kim Y, Lee S, Ishida E, Blaner W . Aldehyde dehydrogenase 1a3 defines a subset of failing pancreatic β cells in diabetic mice. Nat Commun. 2016; 7:12631. PMC: 5013715. DOI: 10.1038/ncomms12631. View

17.

Thorens B, Tarussio D, Maestro M, Rovira M, Heikkila E, Ferrer J . Ins1(Cre) knock-in mice for beta cell-specific gene recombination. Diabetologia. 2014; 58(3):558-65. PMC: 4320308. DOI: 10.1007/s00125-014-3468-5. View

18.

Qi W, Chen X, Holian J, Tan C, Kelly D, Pollock C . Transcription factors Krüppel-like factor 6 and peroxisome proliferator-activated receptor-{gamma} mediate high glucose-induced thioredoxin-interacting protein. Am J Pathol. 2009; 175(5):1858-67. PMC: 2774051. DOI: 10.2353/ajpath.2009.090263. View

19.

Thorens B, Sarkar H, Kaback H, Lodish H . Cloning and functional expression in bacteria of a novel glucose transporter present in liver, intestine, kidney, and beta-pancreatic islet cells. Cell. 1988; 55(2):281-90. DOI: 10.1016/0092-8674(88)90051-7. View

20.

DiFeo A, Martignetti J, Narla G . The role of KLF6 and its splice variants in cancer therapy. Drug Resist Updat. 2008; 12(1-2):1-7. DOI: 10.1016/j.drup.2008.11.001. View